Julie L. Christensen, Ph.D.

Affiliations: 
2003 Stanford University, Palo Alto, CA 
Area:
Immunology, Molecular Biology
Google:
"Julie Christensen"
Cross-listing: Neurotree

Parents

Sign in to add mentor
Irving L. Weissman grad student 2003 Stanford
 (Mechanisms and mediators of hematopoietic stem cell fate.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Domen J, Christensen JL, Gille D, et al. (2015) Cryopreserved, ex vivo expanded allogeneic myeloid progenitor cell product protects neutropenic mice from a lethal fungal infection. Cell Transplantation
Smith-Berdan S, Gille D, Weissman IL, et al. (2007) Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood. 110: 1370-8
Sherwood RI, Christensen JL, Weissman IL, et al. (2004) Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells (Dayton, Ohio). 22: 1292-304
Sherwood RI, Christensen JL, Conboy IM, et al. (2004) Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell. 119: 543-54
Balsam LB, Wagers AJ, Christensen JL, et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 428: 668-73
Christensen JL, Wright DE, Wagers AJ, et al. (2004) Circulation and chemotaxis of fetal hematopoietic stem cells. Plos Biology. 2: E75
Wagers AJ, Sherwood RI, Christensen JL, et al. (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science (New York, N.Y.). 297: 2256-9
Wagers AJ, Christensen JL, Weissman IL. (2002) Cell fate determination from stem cells. Gene Therapy. 9: 606-12
Christensen JL, Weissman IL. (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proceedings of the National Academy of Sciences of the United States of America. 98: 14541-6
Wright DE, Cheshier SH, Wagers AJ, et al. (2001) Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 97: 2278-85
See more...